Similarly,
Specific mobile application suicide provides:
A mobile phone application designed to provide specific suicide therapy has reduced suicidal behavior in high -risk psychiatric hospitalized patients. Moreover, according to a new study by scientists from the Yale School of Medicine and Ohio State University Wexner Medical Center and College of Medicine.
The study, published on August 8, 2025 Jama Network Opennoted that the application, OTX-202, reduced the recurrence of post-discharge suicide attempts by 58.3% in patients who had already tried to commit suicide. Furthermore, This reduction is an essential achievement for a group particularly vulnerable to repeated suicidal behavior, the researchers said.
Application users have also experienced supported reductions in suicidal thoughts up to 24 weeks after psychiatric hospitalization, according to the study. Nevertheless, On the other hand. Meanwhile, patients who used an active control application in addition specific mobile application suicide provides to treatment as usual showed an early improvement, but suicidal thoughts rebounded in week 24.
These results suggest that OTX-202 can help preserve long-term mental health gains during the high-risk period depending on the hospital’s exit. Meanwhile, the study.
“Although specific suicide therapy is very effective in reducing suicidal thoughts. Moreover, impulses, finding therapists who know how to make this vital therapy after leaving the hospital can be difficult. Meanwhile, OTX-202 provides a possible solution to this problem. Moreover, “said the study co-prime, Craig Bryan, PsyD, professor of Ohio State prevention program.
Suicide remains among the 10 main causes of death in the United States. However, This is the second cause of death among individuals from 10 to 14 and 25 to 34 years old, the third main cause among the 15 to 24 year olds and the fourth main cause among the 35 to 44 year olds. Consequently, Since specific mobile application suicide provides 1999, suicide rates have increased by more than 33%. Therefore,
Each year, more than a million adults adopt non -mortal suicidal behavior and nearly 500,000 are hospitalized for suicide attempts. Attempts at suicide. suicide also cost the health system in the United States and a larger economy, or $ 500 billion per year, highlighting the urgent need for evolutionary, effective and economically viable interventions. Suicide is the only superior killer without any prescription product for the vast majority of patients at risk.
“The weeks. months following a suicide crisis and the release of a hospital are among the most risky periods of suicide and mortality attempts, which makes it imperative to offer interventions effective and specific to suicide during this vulnerable window. OTX-202 meets this critical need, “said Committee Patricia Simon, PHD, assistant professor at the Yale School of Medicine.
The OTX-202, developed by Yes Therapeutics, offers specific mobile application suicide provides an evolutionary and profitable approach during this critical gap.
OTX-202 tests by Yale. Ohio State researchers involved a randomized multi-site randomized trial with 339 psychiatric hospitals from six various hospitals in the United States.
Participants were randomly assigned to the OTX-202 application or an active control application, both in addition to their usual treatment. The OTX-202 application delivered a specific suicide therapy while the control application included security planning and psychoeducation.
Compared to active control. patients using OTX-202 were significantly more likely to show a clinical improvement, as measured by the global clinical printing of the gravity of the suicide change scale (CGI-SSC). The CGI is widely used because it provides a standardized measurement. evaluated by clinicians of the severity of the symptoms and the improvement over time, allowing a coherent evaluation between various populations of patients and the processing environments.
Patients. those who deal with them do not specific mobile application suicide provides have access to reliable and effective tools and resources to reduce the risk of future suicide. This population undoubtedly faces the largest difference in access to effective interventions of any leading killer. The potential impact of clinical health and the population of this new option is extraordinary. We incredibly appreciate the support provided by all those involved. in particular the National Institute of Mental Health (NIMH) which financed the study. “”
Seth Feurstein, MD, JD, principal author, member of the Faculty of Yale
The authors of Yale include Patricia Simon, PHD; Samuel T. Wilkinson, MD; Lauren Astorino, MSN, APRN; ALECIA D. DAGER, PHD; and Seth Feurstein, md, jd.
The authors of the Ohio State include Craig Bryan, Psyd; Kristen M. Carpenter, PHD; Luke Misquitta, MD; Katherine Brownlowe, MD; Lauren R. Khazem, PHD; Jarred Hay and Austin G. Starkey.
Funding support: This research was partly specific mobile application suicide provides supported by Yes Therapeutics Inc. by a subsidy from the National Institute of Mental Health (R42MH123357).
The study was funded by a subsidy from the National Institute of Mental Health. The content is only the responsibility of the authors. does not necessarily represent the official opinions of the National Institutes of Health.
Specific mobile application suicide provides
Further reading: Will men finally assume the mental charge of contraception thanks to the YCT-529 pill perhaps soon marketed? – An indigenous case of the Western Nile Virus detected in the Var – Thousands of cases of chikungunya reported – the press of Tunisia – Genetic risk of depression linked to the response of the mute brain to victories and losses – Here is the age at which your body begins to age more quickly, according to a study.